background
middl
east
respiratori
syndrom
coronaviru
merscov
caus
sever
lower
respiratori
tract
infect
peopl
previou
studi
suggest
dromedari
camel
reservoir
viru
test
presenc
merscov
dromedari
camel
farm
qatar
link
two
human
case
infect
octob
took
nose
swab
rectal
swab
blood
sampl
camel
qatari
farm
test
swab
rtpcr
amplifi
cation
target
e
gene
upe
nucleocapsid
n
gene
open
read
frame
orf
pcr
posit
sampl
test
diff
erent
merscov
specifi
c
pcr
obtain
sequenc
use
phylogent
analysi
togeth
sequenc
link
human
case
human
case
test
serum
sampl
camel
igg
immunofl
uoresc
assay
protein
microarray
viru
neutralis
assay
interpret
studi
provid
virolog
confi
rmation
merscov
camel
suggest
recent
outbreak
aff
ect
human
be
camel
conclud
whether
peopl
farm
infect
camel
vice
versa
third
sourc
respons
emerg
betacoronavirusmiddl
east
respiratori
syndrom
coronaviru
merscov
caus
ill
characteris
predominantli
mildtosever
respiratori
complaint
patient
requir
admiss
hospit
pneumon
acut
respiratori
distress
syndrom
old
age
presenc
comorbid
immunosuppress
seem
increas
risk
infect
associ
sever
form
diseas
howev
patient
remain
asymptomat
mildli
symptomat
atyp
present
gastroenter
occur
dec
laboratoryconfi
rmed
case
includ
death
report
case
directli
indirectli
link
middl
east
region
includ
saudi
arabia
qatar
unit
arab
emir
kuwait
oman
jordan
coronavirus
resid
mani
anim
host
adapt
diff
erent
speci
includ
peopl
merscov
belong
lineag
c
betacoronavirus
associ
bat
closest
rel
merscov
identifi
ed
vesper
bat
europ
asia
south
africa
notabl
coronoviru
abl
replic
variou
bat
cell
line
molecular
clock
date
epidemiolog
unlink
human
merscov
isol
estim
diverg
common
ancestor
cluster
isol
eastern
part
arabian
peninsula
diverg
late
fi
nding
suggest
report
merscov
divers
human
be
result
sever
independ
geograph
structur
zoonot
event
unknown
reservoir
middl
east
humantohuman
transmiss
note
especi
healthcar
set
household
thought
rel
ineffi
cient
determin
circul
merscov
human
be
maintain
mitig
chain
transmiss
identifi
cation
possibl
anim
reservoir
mode
transmiss
need
limit
avail
exposur
histori
patient
suggest
contact
livestock
includ
dromedari
camel
might
role
addit
recent
investig
provid
evid
circul
merscov
relat
viru
dromedari
camel
merscov
spike
protein
bind
antibodi
viru
neutralis
antibodi
report
dromedari
camel
diff
erent
region
includ
oman
egypt
viru
shed
could
detect
therefor
signifi
canc
observ
remain
issu
debat
studi
aim
assess
presenc
merscov
dromedari
camel
farm
qatar
link
two
human
case
merscov
octob
qatar
suprem
council
health
record
two
case
laboratori
confi
rmed
merscov
case
involv
man
owner
farm
visit
regularli
patient
substanti
contact
anim
includ
camel
sheep
pigeon
hen
histori
travel
outsid
qatar
week
becom
ill
merscov
infect
diagnos
e
gene
upe
pcr
sputum
sampl
collect
oct
nation
virolog
laboratori
qatar
case
involv
male
employe
farm
own
case
identifi
ed
closecontact
investig
case
report
oct
underli
medic
condit
recent
travel
histori
regular
contact
anim
farm
merscov
infect
diagnos
throat
swab
taken
oct
nation
virolog
laboratori
qatar
diagnosi
case
confi
rmed
n
gene
pcr
public
health
england
qatari
author
support
epidemiolog
investig
farm
within
week
diagnosi
fi
rst
case
includ
collect
variou
clinic
sampl
farm
dromedari
camel
full
detail
outbreak
investig
describ
elsewher
collect
serum
rectal
swab
nasal
swab
camel
present
premis
two
men
contact
anim
experienc
anim
handler
fi
xate
camel
nose
pinch
sampl
obtain
swab
fl
ock
swab
floqswab
copan
improv
diagnost
brescia
itali
insert
deep
one
nostril
camel
sampl
swab
put
tube
contain
viral
transport
mediumutm
copan
diagnost
brescia
itali
addit
obtain
fi
stool
sampl
three
diff
erent
cage
sampl
collect
done
jointli
communic
diseas
control
outbreak
rapid
respons
team
public
health
depart
anim
health
team
use
full
personalprotect
equip
includ
mask
goggl
dispos
gown
glove
head
cover
handl
anim
environment
human
sampl
serum
sampl
store
sampl
store
ship
netherland
dri
ice
test
nose
swab
two
independ
rtpcr
target
specifi
c
merscov
upe
nucleocapsid
n
gene
one
laboratori
depart
virosci
erasmu
medic
center
rotterdam
netherland
rtpcr
test
third
target
anoth
laboratori
nation
institut
public
health
environ
bilthoven
netherland
inocul
vero
cell
h
cellcultur
medium
contain
sampl
camel
nose
rectal
swab
merscov
emc
isol
posit
control
wash
cell
incub
medium
contain
fetal
bovin
serum
stain
formaldehydefi
xed
cell
infect
merscov
use
heatinactiv
min
camel
sera
merscov
patient
serum
accord
standard
protocol
fl
uorescein
isothiocyanateconjug
antibodi
second
step
isol
rna
swab
medium
cultur
supernat
qiaamp
viral
rna
minikit
qiagen
hilden
germani
elut
camel
merscov
rna
quantifi
ed
abi
prism
taqman
fast
viru
master
mix
appli
biosystem
bleiswijk
netherland
isol
rna
one
taqman
mix
u
uracilnglycosylas
primer
probe
target
n
gene
upe
describ
elsewher
use
rna
dilut
isol
merscov
isol
emc
stock
standard
control
rna
revers
transcrib
superscript
iii
fi
rst
strand
synthesi
system
invitrogen
bleiswijk
netherland
random
hexam
cdna
use
amplifi
six
diff
erent
camel
merscov
fragment
includ
partial
spike
gene
use
pfu
ultra
ii
fusion
hs
dna
polymeras
agil
technolog
santa
clara
ca
usa
pcr
follow
one
initi
denatur
step
min
follow
cycl
min
fi
nal
extens
min
amplifi
ed
camel
merscov
fragment
sequenc
directli
strand
bigdy
termin
version
cycl
sequenc
kit
abi
prism
genet
analys
appli
biosystem
gener
phyml
phylogenet
tree
seaview
softwar
approxim
likelihoodratio
test
base
shimodairahasegawalik
procedur
use
gener
time
revers
substitut
model
use
nearest
neighbour
interchang
subtre
prune
regraftingbas
tree
search
algorithm
estim
tree
topolog
rna
human
sampl
sputum
qatar
case
throat
swab
qatar
case
extract
nuclisen
easymag
system
basingstok
uk
viral
sequenc
two
human
case
isol
techniqu
camel
case
refer
depart
public
health
england
london
uk
use
primer
design
sequenc
merscov
bat
coronavirus
amplifi
entir
genom
human
case
sequenc
illumina
miseq
sequenc
subsequ
indic
case
case
sequenc
obtain
studi
deposit
genbank
follow
access
number
partial
camelmerscov
camel
partial
test
sera
presenc
igg
antibodi
reactiv
merscov
residu
sever
acut
respiratori
syndrom
coronaviru
sarscov
residu
human
coronaviru
residu
antigen
describ
previous
report
result
rel
mean
fl
uoresc
intens
rfu
set
quadrupl
spot
per
antigen
igg
antibodi
test
anticamel
igm
conjug
avail
viru
neutralis
serum
sampl
heatinactiv
incub
min
prepar
twofold
serial
dilut
well
plate
start
dilut
merscov
dilut
iscov
modifi
ed
dulbecco
medium
imdm
supplement
penicillin
streptomycin
fetal
bovin
serum
dilut
tcid
per
ml
ad
viru
suspens
plate
plate
incub
h
next
incub
virusserum
mixtur
well
plate
contain
vero
cell
h
wash
phosphat
buff
er
salin
incub
imdm
fetal
bovin
serum
day
sponsor
studi
role
studi
design
data
collect
data
analysi
data
interpret
write
report
correspond
author
full
access
data
studi
fi
nal
respons
decis
submit
public
sampl
camel
obtain
oct
tabl
fi
gure
nose
swab
specimen
fi
camel
posit
three
assay
upe
n
gene
one
sampl
react
two
assay
fi
camel
test
posit
one
rtpcr
assay
subsequ
sampl
subject
pcr
assay
target
spike
gene
merscov
nucleotid
obtain
fragment
sequenc
defi
nitiv
confi
rmation
sequenc
confi
rmed
presenc
sequenc
specifi
c
merscov
three
camel
align
partial
spike
gene
sequenc
known
human
merscov
sequenc
includ
determin
two
relat
human
case
human
merscov
isol
show
ident
sequenc
diff
ere
emc
merscov
use
routin
erasmu
mc
laboratori
one
nucleotid
three
camel
merscov
sequenc
obtain
approach
ident
viru
cultur
attempt
success
although
one
sampl
test
camel
yield
posit
rtpcr
supernat
tabl
stain
fi
xed
virusinfect
cell
data
shown
passag
viru
vero
cell
howev
success
addit
serum
camel
show
low
level
merscov
determin
rtpcr
camel
sera
test
neg
data
shown
rectal
swab
faecal
materi
neg
merscov
test
reactiv
upe
n
gene
rtpcr
sequenc
viru
camel
primer
specifi
c
merscov
render
six
diff
erent
fragment
cover
kb
across
merscov
genom
fi
gure
fragment
nucleotid
locat
fragment
fragment
spike
gene
fragment
sequenc
obtain
human
case
farm
diff
ere
one
nucleotid
diff
erenc
one
merscov
emc
isol
diff
er
eight
nucleotid
camel
merscov
align
diverg
nucleotid
fragment
data
shown
kb
concaten
sequenc
fragment
use
phyml
phylogenet
analysi
camel
merscov
cluster
viral
sequenc
obtain
two
human
case
relat
farm
sequenc
hafralbatin
next
closest
rel
fi
gure
less
stringent
method
analysi
show
limit
bootstrap
support
data
shown
line
rel
limit
sequenc
variat
within
fragment
camel
sera
posit
immunofl
uoresc
assay
test
dilut
fi
gure
serum
sampl
camel
test
diff
erent
dilut
microarray
note
reactiv
merscov
antigen
sarscov
antigen
reactiv
human
coronaviru
antigen
proxi
betacoronaviru
vari
neg
less
cutoff
valu
satur
signal
data
shown
consist
array
data
serum
sampl
merscov
neutralis
capac
titr
vari
fi
gure
also
note
strong
correl
microarray
titr
viru
neutralis
antibodi
titr
fi
gure
two
camel
highest
merscov
load
swab
shown
taqman
assay
camel
rel
low
serum
neutralis
titr
present
knowledg
fi
rst
virolog
confi
rmation
merscov
dromedari
camel
panel
other
previous
report
merscov
neutralis
antibodi
dromedari
camel
canari
island
oman
egypt
suggest
circul
merscov
merscovlik
viru
camel
high
preval
antibodi
titr
report
camel
oman
egypt
suggest
widespread
circul
howev
virolog
test
unabl
detect
merscov
viral
sequenc
camel
probabl
faecal
serum
sampl
analys
addit
shed
kinet
merscov
camel
human
be
unknown
therefor
inter
pretat
neg
rtpcr
result
screen
diffi
cult
posit
neg
predict
valu
remain
determin
outbreak
report
show
evid
presenc
viru
six
camel
accord
intern
recommend
criteria
two
independ
rtpcr
target
furthermor
use
sequenc
confi
rmation
addit
test
increas
level
certaintydur
emerg
diseas
outbreak
option
valid
assay
clinic
test
limit
discrep
assay
explain
diff
erenc
detect
limit
diff
erenc
specifi
citi
primer
set
studi
n
gene
rtpcr
yield
four
addit
weak
posit
result
could
confi
rmed
method
individu
rtpcr
identifi
cation
made
one
anim
case
could
result
misprim
repres
presenc
level
viru
around
detect
limit
expect
end
infect
cycl
nevertheless
result
suggest
widespread
recent
outbreak
herd
coincid
infect
two
peopl
data
taken
evid
infect
peopl
camel
comparison
sequenc
data
gene
concaten
kb
sequenc
human
camel
virus
show
virus
similar
distinct
notabl
sampl
camel
peopl
analys
diff
erent
laboratori
netherland
uk
data
provid
show
proof
camel
infect
merscov
sequenc
diff
erenc
human
anim
virus
farm
base
avail
overlap
sequenc
small
conclud
whether
peopl
farm
infect
camel
vice
versa
anoth
possibl
peopl
camel
infect
third
yet
unknown
sourc
although
addit
sequenc
might
provid
improv
resolut
probabl
provid
conclus
evid
import
unknown
exact
time
infect
infect
peopl
camel
viru
enter
farm
either
peopl
camel
infect
observ
would
probabl
result
chain
transmiss
introduc
mutat
identifi
seroneg
anim
pcr
posit
anim
merscov
neutralis
antibodi
sampl
probabl
took
place
rel
late
outbreak
farm
detail
analysi
outbreak
includ
test
addit
anim
environment
sampl
ongo
attempt
obtain
full
merscov
genom
human
anim
specimen
exclud
possibl
common
livestock
speci
includ
cattl
sheep
goat
anim
includ
wild
speci
involv
spread
merscov
confi
rmation
sourc
await
recommend
detail
case
histori
taken
case
merscov
includ
review
anim
exposur
includ
anim
product
target
prospect
serosurvey
determin
risk
factor
associ
human
infect
search
pubm
articl
publish
english
dec
search
term
novel
coronaviru
emc
merscov
identifi
ed
report
link
middl
east
respiratori
syndrom
coronaviru
merscov
one
report
describ
detect
one
bat
specimen
singl
bp
fragment
highli
conserv
area
coronaviru
genom
ident
human
merscov
laboratori
isol
emc
report
describ
fi
rst
detect
merscov
dromedari
camel
farm
qatar
link
human
case
diseas
studi
provid
proof
merscov
infect
dromedari
camel
qatar
result
suggest
simultan
occurr
merscov
outbreak
peopl
camel
basi
present
data
conclud
whether
peopl
farm
infect
camel
vice
versa
anoth
possibl
peopl
camel
could
infect
third
yet
unknown
sourc
recommend
detail
case
histori
taken
includ
review
anim
exposur
includ
anim
product
target
prospect
serosurvey
determin
risk
factorsoth
contact
individu
infectionar
associ
human
infect
blh
wrote
report
drew
fi
gure
gener
analys
interpret
data
shsad
mma
mpgk
coordin
studi
wrote
report
interpret
data
cbemr
wrote
report
drew
fi
gure
literatur
search
analys
interpret
data
vsr
drew
fi
gure
gener
analys
interpret
data
mg
rm
ab
gener
interpret
data
gjg
gener
analys
interpret
data
mj
gener
analys
data
ef
led
fi
eld
investig
obtain
sampl
collect
interpret
data
ad
supervis
fi
eld
outbreak
manag
collect
interpret
data
hg
fa
supervis
anim
health
fi
eld
investig
mat
coordin
studi
interpret
data
saam
coordin
studi
hear
led
outbreak
manag
collect
interpret
data
aak
coordin
studi
interpret
data
admeo
wrote
report
interpret
data
blh
admeo
vsr
hold
pend
patent
merscov
admeo
scientifi
c
advis
viroclin
bioscienc
author
declar
confl
ict
interest
